Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Jasper Therapeutics, Inc. JSPR

Set alert

Price alert · JSPR

All alert types
0.51 USD -0.01 -2.35%

At close · Nov 2

0.51 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
0.51 × 2
Ask
0.51 × 2
0.4975 Day range 0.55
0.315 52-week range 2.42
YTD
-72.24%
1 year
-77.72%
Open
0.5193
Prev close
0.5202
Mkt cap
16.90M
Vol
452.00K
Avg vol
496.18K
EPS
-1.04
P/E
0.00
Div yield
0.00%
More statistics
Low
0.4975
High
0.55
Forward P/E
-4.89
Beta
2.20
Short ratio
9.32
Inst. own
100.34%
Dividend
0.00
Ex-div date
Earnings
Aug 13, 2024
50-d avg
21.46
200-d avg
21.97
1y target
68.78

6M chart

Chart tools
Interval
1m5m15m30m

Signals (21)
NameDateAgo
MACD: Buy SignalOct 23, 20261 week ago
MACD: Sell SignalSep 30, 20261 month ago
MACD: Buy SignalSep 29, 20261 month ago
SMA: BearishSep 11, 20261 month ago
SMA: BearishAug 20, 20262 months ago
MACD: Sell SignalAug 20, 20262 months ago
SMA: BullishAug 10, 20262 months ago
MACD: Buy SignalAug 10, 20262 months ago
SMA: BullishJul 30, 20263 months ago
SMA: BearishJul 29, 20263 months ago
MACD: Sell SignalJul 29, 20263 months ago
SMA: BearishJul 20, 20263 months ago
SMA: BullishJul 17, 20263 months ago
RSI: OverboughtJul 17, 20263 months ago
SMA: BullishJul 14, 20263 months ago
RSI: OversoldJun 26, 20264 months ago
MACD: Buy SignalJun 22, 20264 months ago
MACD: Sell SignalJun 1, 20265 months ago
RSI: OversoldJun 1, 20265 months ago
MACD: Buy SignalMay 22, 20265 months ago
MACD: Sell SignalMay 18, 20265 months ago

Financial health

Altman Z-Score

-45.54 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

0 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 1

Valuation

P/E -0.5×
FY 2019: -3.5×FY 2020: -0.5×FY 2021: -2.9×FY 2022: -0.5×FY 2023: -1.3×FY 2024: -4.4×FY 2025: -0.5×
FY 2019 5y median -1.3× FY 2025
P/S 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 8.5×
FY 2019: 0.8×FY 2020: -0.5×FY 2021: 1.3×FY 2022: 0.5×FY 2023: 1.1×FY 2024: 5.1×FY 2025: 8.5×
FY 2019 5y median 1.3× FY 2025
P/FCF -0.5×
FY 2019: -8.8×FY 2020: -0.9×FY 2021: -2.5×FY 2022: -0.4×FY 2023: -1.6×FY 2024: -4.9×FY 2025: -0.5×
FY 2019 5y median -1.6× FY 2025
EV/EBITDA -0.1×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: -0.3×FY 2022: 0.5×FY 2023: 0.0×FY 2024: -3.5×FY 2025: -0.1×
FY 2019 5y median -0.1× FY 2025
EV/Sales 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -220.0%
FY 2019: -11.4%FY 2020: -106.1%FY 2021: -40.4%FY 2022: -263.5%FY 2023: -63.5%FY 2024: -20.3%FY 2025: -220.0%
FY 2019 5y median -63.5% FY 2025

Profitability

Gross Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -1826.1%
FY 2019: -23.6%FY 2020: 90.1%FY 2021: -44.1%FY 2022: -104.7%FY 2023: -82.2%FY 2024: -115.6%FY 2025: -1826.1%
FY 2019 5y median -104.7% FY 2025
ROIC -338.1%
FY 2019: -18.7%FY 2020: -106.9%FY 2021: -42.8%FY 2022: -121.4%FY 2023: -82.5%FY 2024: -116.0%FY 2025: -338.1%
FY 2019 5y median -116.0% FY 2025
ROA -211.9%
FY 2019: -18.3%FY 2020: -135.6%FY 2021: -32.7%FY 2022: -77.9%FY 2023: -67.9%FY 2024: -89.2%FY 2025: -211.9%
FY 2019 5y median -77.9% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 FY 2025
Operating Income -5.6%
FY 2019: 0.0%FY 2020: -339.1%FY 2021: -78.1%FY 2022: -39.0%FY 2023: -34.5%FY 2024: -10.7%FY 2025: -5.6%
FY 2019 FY 2025
EPS (diluted) 19.2%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 85.3%FY 2022: 61.6%FY 2023: 40.2%FY 2024: 20.9%FY 2025: 19.2%
FY 2019 FY 2025
Free Cash Flow -22.2%
FY 2019: 0.0%FY 2020: -827.7%FY 2021: -97.7%FY 2022: -28.6%FY 2023: -12.7%FY 2024: -20.7%FY 2025: -22.2%
FY 2019 FY 2025

Financial Health

Current Ratio 2.6×
FY 2019: 13.6×FY 2020: 5.2×FY 2021: 11.0×FY 2022: 5.9×FY 2023: 7.2×FY 2024: 5.0×FY 2025: 2.6×
FY 2019 5y median 5.9× FY 2025
Quick Ratio 2.6×
FY 2019: 13.6×FY 2020: 5.2×FY 2021: 11.0×FY 2022: 5.9×FY 2023: 7.2×FY 2024: 5.0×FY 2025: 2.6×
FY 2019 5y median 5.9× FY 2025
Debt / Equity 0.3×
FY 2019: 0.0×FY 2020: -0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.3×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.4×
FY 2019: 0.0×FY 2020: 0.9×FY 2021: 2.7×FY 2022: 0.9×FY 2023: 1.3×FY 2024: 1.0×FY 2025: 0.4×
FY 2019 5y median 1.0× FY 2025
Interest Coverage 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31